Attributes | Values |
---|
rdf:type
| |
description
| - wetenschappelijk artikel (nl)
- наукова стаття, опублікована у квітні 1999 (uk)
- article scientifique publié en 1999 (fr)
- im April 1999 veröffentlichter wissenschaftlicher Artikel (de)
- artículu científicu espublizáu n'abril de 1999 (ast)
- scientific article published on 01 April 1999 (en)
|
publication date
| |
publication date
| |
cites work
| |
cites work
| |
author name string
| |
author name string
| - D M Burger
- P P Koopmans
- Y A Hekster
- E W Wuis
- P W Hugen
- C P Verweij-van Wissen
|
rdfs:label
| - Simultaneous determination of the HIV-protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography (en)
- Simultaneous determination of the HIV-protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography (nl)
|
skos:prefLabel
| - Simultaneous determination of the HIV-protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography (en)
- Simultaneous determination of the HIV-protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography (nl)
|
name
| - Simultaneous determination of the HIV-protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography (en)
- Simultaneous determination of the HIV-protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography (nl)
|
title
| |
title
| - Simultaneous determination of the HIV-protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography (en)
|
page(s)
| |
page(s)
| |
instance of
| |
instance of
| |
main subject
| |
main subject
| |
PubMed ID
| |
PubMed ID
| |
PubMed ID
| |
published in
| |
published in
| |
issue
| |
volume
| |
issue
| |
volume
| |
DOI
| |
DOI
| |
DOI
| - 10.1016/S0378-4347(99)00079-1
|
describes a project that uses
| |
describes a project that uses
| |
is about
of | |
is cites work
of | - International interlaboratory quality control program for measurement of antiretroviral drugs in plasma
- Pharmacokinetics of adjusted-dose lopinavir-ritonavir combined with rifampin in healthy volunteers
- Pharmacokinetics, food intake requirements and tolerability of once-daily combinations of nelfinavir and low-dose ritonavir in healthy volunteers
- Simultaneous high-performance liquid chromatographic determination of the antiretroviral agents amprenavir, nelfinavir, ritonavir, saquinavir, delavirdine and efavirenz in human plasma
- Simultaneous determination of five HIV protease inhibitors nelfinavir, indinavir, ritonavir, saquinavir and amprenavir in human plasma by LC/MS/MS.
- High-performance liquid chromatography of HIV protease inhibitors in human biological matrices
- Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extractio
- [Adherence to antiretroviral therapy measured by pill count and drug serum concentrations. Variables associated with a bad adherence]
- Application of rat in situ single-pass intestinal perfusion in the evaluation of presystemic extraction of indinavir under different perfusion rates
- Maintenance of indinavir by dose adjustment in HIV-1-infected patients with indinavir-related toxicity
- Simple and rapid high-performance liquid chromatographic method for nelfinavir, M8 nelfinavir metabolite, ritonavir and saquinavir assay in plasma
- Sensitive liquid chromatographic assay for amprenavir, a human immunodeficiency virus protease inhibitor, in human plasma, cerebrospinal fluid and semen
- Simultaneous quantitative determination of the HIV protease inhibitors indinavir, amprenavir, ritonavir, lopinavir, saquinavir, nelfinavir and the nelfinavir active metabolite M8 in plasma by liquid chromatography
- Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir and nelfinavir in human plasma by high-performance liquid chromatography.
- Simultaneous determination of the HIV-protease inhibitors indinavir, amprenavir, ritonavir, saquinavir and nelfinavir in human plasma by reversed-phase high-performance liquid chromatography.
- Determination of twelve antiretroviral agents in human plasma sample using reversed-phase high-performance liquid chromatography.
- High-throughput simultaneous determination of the HIV protease inhibitors indinavir and L-756423 in human plasma using semi-automated 96-well solid phase extraction and LC-MS/MS
- SIMULTANEOUS LIQUID CHROMATOGRAPHIC DETERMINATION OF INDINAVIR, SAQUINAVIR, AND RITONAVIR IN HUMAN PLASMA WITH COMBINED ULTRAVIOLET ABSORBANCE AND ELECTROCHEMICAL DETECTION
- Quantification of plasma and intracellular levels of the HIV protease inhibitor ritonavir by competitive ELISA.
- Pharmacokinetics of indinavir combined with low-dose ritonavir in human immunodeficiency virus type 1-infected children.
- Validation of high-performance liquid chromatography methods for determination of zidovudine, stavudine, lamivudine and indinavir in human plasma
|
is cites work
of | |